J Korean Neurosurg Soc.  2001 Mar;30(3):342-348.

SPECT Imaging of Dopamine Transporter with [I-123] IPT in Normal Controls and Parkinson's Patients

Affiliations
  • 1Department of Nuclear Medicine, The Catholic University of Korea, Seoul, Korea.
  • 2Department of Neurosurgery, The Catholic University of Korea, Seoul, Korea.

Abstract


OBJECTIVES
Dopamine transporter concentrations have been known to decrease in Parkinson's disease(PD). The aim of the present study was to evaluate the correlation between SPECT measurements of [I-123]N-(3-iodopropene-2-yl)-2beta-carbomethoxy-3beta-(4-chlorophenyl) tropane(IPT) as an imaging agent for measuring changes in transporter concentrations with PD.
PATIENTS AND METHODS
IPT labelled with 4.87+/-1.29mCi(180.19+/-47.73 MBq) of [I-123] was intravenously injected into 23 patients(age:58+/-12) with PD and three normal controls(NC)(age:37+/-7) as bolus. Brain SPECT were then performed at 1 hour and 2 hours after injection on a double headed camera. The statistical parameters were the contrast ratio of left basal ganglia(BG) and right basal ganglia to occipital cortex(OCC) per milli curies of injected radiotracer at 1 hour and 2 hours. The correlations were evaluated between these parameters and Hoehn-Yahr classification of the patients.
RESULTS
The(BG-OCC)/OCC/mCi ratios at 1 hour and 2 hours for PD and NC were 0.14+/-0.07 and 0.27+/-0.07(1 hour) and 0.12+/-0.07 and 0.34+/-0.04(2 hour), respectively. The(BG-OCC)/OCC/mCi ratios of Parkinson's disease were decreased with higher grade of Hoehn-Yahr classification of the patients. The ratio between BG and OCC for PD were clearly separated from NC and may be useful outcome measures for clinical diagnosis.
CONCLUSION
The findings suggest that IPT may be a very useful tracer for early diagnosis and treatment of PD and study of dopamine re-uptake site.

Keyword

IPT; Brain SPECT; Dopamine trasporter; Parkinson's diseases

MeSH Terms

Basal Ganglia
Brain
Classification
Diagnosis
Dopamine Plasma Membrane Transport Proteins*
Dopamine*
Early Diagnosis
Head
Humans
Outcome Assessment (Health Care)
Parkinson Disease
Tomography, Emission-Computed, Single-Photon*
Dopamine
Dopamine Plasma Membrane Transport Proteins
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr